{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:51:12Z","timestamp":1792435872329,"version":"4.5.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Immune dysfunction is implicated in the aetiology of psychiatric, neurodevelopmental, and neurodegenerative conditions, but the issue of causality remains unclear impeding attempts to develop new interventions. Using genomic data on protein and gene expression across blood and brain, we assessed evidence of a potential causal role for 736 immune response-related biomarkers on 7 neuropsychiatric conditions by applying Mendelian randomization (MR) and genetic colocalisation analyses. A systematic three-tier approach, grouping biomarkers based on increasingly stringent criteria, was used to appraise evidence of causality (passing MR sensitivity analyses, colocalisation, False Discovery Rate and Bonferroni thresholds). We provide evidence for a potential causal role of 29 biomarkers for 7 conditions. The identified biomarkers suggest a role of both brain specific and systemic immune response in the aetiology of schizophrenia, Alzheimer\u2019s disease, depression, and bipolar disorder. Of the identified biomarkers, 20 are therapeutically tractable, including\n                    <jats:italic>ACE<\/jats:italic>\n                    ,\n                    <jats:italic>TNFRSF17<\/jats:italic>\n                    ,\n                    <jats:italic>SERPING1<\/jats:italic>\n                    ,\n                    <jats:italic>AGER<\/jats:italic>\n                    and\n                    <jats:italic>CD40<\/jats:italic>\n                    , with drugs currently approved or in advanced clinical trials. Based on the largest available selection of plasma immune-response related biomarkers, our study provides insight into possible influential biomarkers for the aetiology of neuropsychiatric conditions. These genetically prioritised biomarkers now require examination to further evaluate causality, their role in the aetiological mechanisms underlying the conditions, and therapeutic potential.\n                  <\/jats:p>","DOI":"10.1038\/s41380-025-03032-x","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T13:38:23Z","timestamp":1745588303000},"page":"4487-4496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Immunological drivers and potential novel drug targets for major psychiatric, neurodevelopmental, and neurodegenerative conditions"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2019-7897","authenticated-orcid":false,"given":"Christina","family":"Dardani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie W.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5883-9605","authenticated-orcid":false,"given":"Hannah J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dheeraj","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3586-0927","authenticated-orcid":false,"given":"Evie","family":"Stergiakouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2284-5744","authenticated-orcid":false,"given":"Jakob","family":"Grove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0198-4588","authenticated-orcid":false,"given":"Andrew M.","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Havdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gibran","family":"Hemani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1407-8314","authenticated-orcid":false,"given":"George","family":"Davey Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7918-2040","authenticated-orcid":false,"given":"Tom G.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0924-3247","authenticated-orcid":false,"given":"Tom R.","family":"Gaunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4935-9220","authenticated-orcid":false,"given":"Golam M.","family":"Khandaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"3032_CR1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"Collaborators, G. B. D. 2019 M. D","year":"2022","unstructured":"Collaborators, G. B. D. 2019 M. D. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137\u201350.","journal-title":"Lancet Psychiatry"},{"key":"3032_CR2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"T Vos","year":"2017","unstructured":"Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390:1211\u201359.","journal-title":"Lancet"},{"key":"3032_CR3","first-page":"239821281879927","volume":"2","author":"NJ Bray","year":"2018","unstructured":"Bray NJ, O\u2019Donovan MC. The genetics of neuropsychiatric disorders. Brain Neurosci Adv. 2018;2:2398212818799271.","journal-title":"Brain Neurosci Adv."},{"key":"3032_CR4","doi-asserted-by":"crossref","unstructured":"Howes OD, Thase ME, Pillinger T. Treatment resistance in psychiatry: state of the art and new directions. Mol. Psychiatry. 2021;27:1\u201315.","DOI":"10.1038\/s41380-021-01200-3"},{"key":"3032_CR5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1126\/science.370.6515.392","volume":"370","author":"K Kupferschmidt","year":"2020","unstructured":"Kupferschmidt K. In new strategy, wellcome trust takes on global health concerns. Science. 2020;370:392.","journal-title":"Science"},{"key":"3032_CR6","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4088\/JCP.12r07694","volume":"73","author":"M Udina","year":"2012","unstructured":"Udina M, Castellv\u00ed P, Moreno-Espa\u00f1a J, Navin\u00e9s R, Vald\u00e9s M, Forns X, et al. Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry. 2012;73:1128\u201338.","journal-title":"J Clin Psychiatry"},{"key":"3032_CR7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.biopsych.2009.03.015","volume":"66","author":"NA Harrison","year":"2009","unstructured":"Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry. 2009;66:407\u201314.","journal-title":"Biol Psychiatry"},{"key":"3032_CR8","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21:1696.","journal-title":"Mol Psychiatry"},{"key":"3032_CR9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/schbul\/sbx035","volume":"44","author":"AK Wang","year":"2018","unstructured":"Wang AK, Miller BJ. Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression. Schizophr Bull. 2018;44:75\u201383.","journal-title":"Schizophr Bull"},{"key":"3032_CR10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","volume":"72","author":"E Setiawan","year":"2015","unstructured":"Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G, et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry. 2015;72:268\u201375.","journal-title":"JAMA Psychiatry"},{"key":"3032_CR11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1176\/appi.ajp.2013.13010086","volume":"171","author":"ME Benros","year":"2014","unstructured":"Benros ME, Pedersen MG, Rasmussen H, Eaton WW, Nordentoft M, Mortensen PB. A nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis. Am J Psychiatry. 2014;171:218\u201326.","journal-title":"Am J Psychiatry"},{"key":"3032_CR12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1176\/appi.ajp.2007.07050740","volume":"165","author":"C Dalman","year":"2008","unstructured":"Dalman C, Allebeck P, Gunnell D, Harrison G, Kristensson K, Lewis G, et al. Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am J Psychiatry. 2008;165:59\u201365.","journal-title":"Am J Psychiatry"},{"key":"3032_CR13","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/ije\/dyab151","volume":"51","author":"T-A Hegvik","year":"2022","unstructured":"Hegvik T-A, Chen Q, Kuja-Halkola R, Klungs\u00f8yr K, Butwicka A, Lichtenstein P, et al. Familial co-aggregation of attention-deficit\/hyperactivity disorder and autoimmune diseases: a cohort study based on Swedish population-wide registers. Int J Epidemiol. 2022;51:898\u2013909.","journal-title":"Int J Epidemiol"},{"key":"3032_CR14","volume":"19","author":"J Sun","year":"2022","unstructured":"Sun J, Ludvigsson JF, Ingre C, Piehl F, Wirdefeldt K, Zagai U, et al. Hospital-treated infections in early- and mid-life and risk of Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden. PLoS Med. 2022;19:e1004092.","journal-title":"PLoS Med"},{"key":"3032_CR15","doi-asserted-by":"crossref","unstructured":"Benros ME, Mortensen PB. Role of infection, autoimmunity, atopic disorders, and the immune system in schizophrenia: evidence from epidemiological and genetic studies. Neuroinflammation Schizophr. 2019:141\u201359.","DOI":"10.1007\/7854_2019_93"},{"key":"3032_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43586-021-00091-6","volume":"2","author":"E Sanderson","year":"2022","unstructured":"Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munaf\u00f2 MR, et al. Mendelian randomization. Nat Rev Methods Prim. 2022;2:1\u201321.","journal-title":"Nat Rev Methods Prim"},{"key":"3032_CR17","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23:R89\u2013R98.","journal-title":"Hum Mol Genet"},{"key":"3032_CR18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41569-020-00493-1","volume":"18","author":"MV Holmes","year":"2021","unstructured":"Holmes MV, Richardson TG, Ference BA, Davies NM, Davey Smith G. Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development. Nat Rev Cardiol. 2021;18:435\u201353.","journal-title":"Nat Rev Cardiol"},{"key":"3032_CR19","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1001\/jamapsychiatry.2017.3191","volume":"74","author":"FP Hartwig","year":"2017","unstructured":"Hartwig FP, Borges MC, Horta BL, Bowden J, Davey Smith G. Inflammatory biomarkers and risk of schizophrenia: a 2-sample Mendelian randomization study. JAMA Psychiatry. 2017;74:1226\u201333.","journal-title":"JAMA Psychiatry"},{"key":"3032_CR20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbi.2021.07.009","volume":"97","author":"BI Perry","year":"2021","unstructured":"Perry BI, Upthegrove R, Kappelmann N, Jones PB, Burgess S, Khandaker GM. Associations of immunological proteins\/traits with schizophrenia, major depression and bipolar disorder: A bi-directional two-sample Mendelian randomization study. Brain Behav Immun. 2021;97:176\u201385.","journal-title":"Brain Behav Immun"},{"key":"3032_CR21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/acps.13016","volume":"139","author":"O K\u00f6hler-Forsberg","year":"2019","unstructured":"K\u00f6hler-Forsberg O, Lydholm N, Hjorth\u00f8j C, Nordentoft C, Mors M, Benros O, et al. Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials. Acta Psychiatr Scand. 2019;139:404\u201319.","journal-title":"Acta Psychiatr Scand"},{"key":"3032_CR22","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/0004867419835028","volume":"53","author":"M Cho","year":"2019","unstructured":"Cho M, Lee TY, Kwak Y, Bin, Yoon YB, Kim M, et al. Adjunctive use of anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Aust N Z J Psychiatry. 2019;53:742\u201359.","journal-title":"Aust N Z J Psychiatry"},{"key":"3032_CR23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jamapsychiatry.2019.0779","volume":"76","author":"RS McIntyre","year":"2019","unstructured":"McIntyre RS, Subramaniapillai M, Lee Y, Pan Z, Carmona NE, Shekotikhina M, et al. Efficacy of adjunctive infliximab vs placebo in the treatment of adults with bipolar I\/II depression: a randomized clinical trial. JAMA Psychiatry. 2019;76:783\u201390.","journal-title":"JAMA Psychiatry"},{"key":"3032_CR24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70:31\u201341.","journal-title":"JAMA Psychiatry"},{"key":"3032_CR25","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/npp.2017.258","volume":"43","author":"RR Girgis","year":"2018","unstructured":"Girgis RR, Ciarleglio A, Choo T, Haynes G, Bathon JM, Cremers S, et al. A Randomized, double-blind, placebo-controlled clinical trial of tocilizumab, an interleukin-6 receptor antibody, for residual symptoms in schizophrenia. Neuropsychopharmacology. 2018;43:1317\u201323.","journal-title":"Neuropsychopharmacology"},{"key":"3032_CR26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, Benner C, Hsu Y-H, Richardson TG, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023;622:329\u201338.","journal-title":"Nature"},{"key":"3032_CR27","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa U, Claringbould A, Westra H-J, Bonder MJ, Deelen P, Zeng B, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53:1300\u201310.","journal-title":"Nat Genet"},{"key":"3032_CR28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41588-020-00773-z","volume":"53","author":"AP Wingo","year":"2021","unstructured":"Wingo AP, Liu Y, Gerasimov ES, Gockley J, Logsdon BA, Duong DM, et al. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer\u2019s disease pathogenesis. Nat Genet. 2021;53:143\u20136.","journal-title":"Nat Genet"},{"key":"3032_CR29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41588-023-01300-6","volume":"55","author":"N de Klein","year":"2023","unstructured":"de Klein N, Tsai EA, Vochteloo M, Baird D, Huang Y, Chen C-Y, et al. Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases. Nat Genet. 2023;55:377\u201388.","journal-title":"Nat Genet"},{"key":"3032_CR30","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ajhg.2021.01.012","volume":"108","author":"C Robins","year":"2021","unstructured":"Robins C, Liu Y, Fan W, Duong DM, Meigs J, Harerimana NV, et al. Genetic control of the human brain proteome. Am J Hum Genet. 2021;108:400\u201310.","journal-title":"Am J Hum Genet"},{"key":"3032_CR31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41588-019-0344-8","volume":"1","author":"J Grove","year":"2019","unstructured":"Grove J, Ripke S, Als TD, Mattheisen M, Walters RK, Won H, et al. Identification of common genetic risk variants for autism spectrum disorder. Nat Genet. 2019;1:431\u201344.","journal-title":"Nat Genet"},{"key":"3032_CR32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41588-022-01285-8","volume":"55","author":"D Demontis","year":"2023","unstructured":"Demontis D, Walters GB, Athanasiadis G, Walters R, Therrien K, Nielsen TT, et al. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nat Genet. 2023;55:198\u2013208.","journal-title":"Nat Genet"},{"key":"3032_CR33","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/mp.2015.197","volume":"21","author":"T Otowa","year":"2016","unstructured":"Otowa T, Hek K, Lee M, Byrne EM, Mirza SS, Nivard MG, et al. Meta-analysis of genome-wide association studies of anxiety disorders. Mol Psychiatry. 2016;21:1391\u20139.","journal-title":"Mol Psychiatry"},{"key":"3032_CR34","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/s41591-023-02352-1","volume":"29","author":"TD Als","year":"2023","unstructured":"Als TD, Kurki MI, Grove J, Voloudakis G, Therrien K, Tasanko E, et al. Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses. Nat Med. 2023;29:1832\u201344.","journal-title":"Nat Med"},{"key":"3032_CR35","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41588-021-00857-4","volume":"53","author":"N Mullins","year":"2021","unstructured":"Mullins N, Forstner AJ, O\u2019Connell KS, Coombes B, Coleman JRI, Qiao Z, et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021;53:817\u201329.","journal-title":"Nat Genet"},{"key":"3032_CR36","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","volume":"604","author":"V Trubetskoy","year":"2022","unstructured":"Trubetskoy V, Pardi\u00f1as AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502\u20138.","journal-title":"Nature"},{"key":"3032_CR37","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet. 2019;51:404\u201313.","journal-title":"Nat Genet"},{"key":"3032_CR38","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3945\/ajcn.115.118216","volume":"103","author":"PC Haycock","year":"2016","unstructured":"Haycock PC, Burgess S, Wade KH, Bowden J, Relton C, Davey Smith G. Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies. Am J Clin Nutr. 2016;103:965\u201378.","journal-title":"Am J Clin Nutr"},{"key":"3032_CR39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","volume":"30","author":"S Burgess","year":"2015","unstructured":"Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG, Consortium E-I. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30:543\u201352.","journal-title":"Eur J Epidemiol"},{"key":"3032_CR40","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG, collaboration, C. R. P. C. H. D. genetics. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40:755\u201364.","journal-title":"Int J Epidemiol"},{"key":"3032_CR41","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/ije\/dyw088","volume":"45","author":"DI Swerdlow","year":"2016","unstructured":"Swerdlow DI, Kuchenbaecker KB, Shah S, Sofat R, Holmes MV, White J, et al. Selecting instruments for Mendelian randomization in the wake of genome-wide association studies. Int J Epidemiol. 2016;45:1600\u201316.","journal-title":"Int J Epidemiol"},{"key":"3032_CR42","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","volume":"52","author":"J Zheng","year":"2020","unstructured":"Zheng J, Haberland V, Baird D, Walker V, Haycock PC, Hurle MR, et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat Genet. 2020;52:1122\u201331.","journal-title":"Nat Genet"},{"key":"3032_CR43","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1214\/aoms\/1177731868","volume":"11","author":"A Wald","year":"1940","unstructured":"Wald A. The fitting of straight lines if both variables are subject to error. Ann Math Stat. 1940;11:284\u2013300.","journal-title":"Ann Math Stat"},{"key":"3032_CR44","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512\u201325.","journal-title":"Int J Epidemiol"},{"key":"3032_CR45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289\u2013300.","journal-title":"J R Stat Soc Ser B"},{"key":"3032_CR46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-genom-083117-021731","volume":"19","author":"S Burgess","year":"2018","unstructured":"Burgess S, Foley CN, Zuber V. Inferring causal relationships between risk factors and outcomes from genome-wide association study data. Annu Rev Genomics Hum Genet. 2018;19:303\u201327.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"3032_CR47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10:e1004383.","journal-title":"PLoS Genet"},{"key":"3032_CR48","doi-asserted-by":"publisher","unstructured":"Robinson JW, Hemani G, Babaei MS, Huang Y, Baird DA, Tsai EA, et al. An efficient and robust tool for colocalisation: pair-wise conditional and colocalisation (PWCoCo). bioRxiv:2022.08.08.503158 [Preprint]. 2022. https:\/\/doi.org\/10.1101\/2022.08.08.503158.","DOI":"10.1101\/2022.08.08.503158"},{"key":"3032_CR49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ije\/dys066","volume":"42","author":"A Fraser","year":"2013","unstructured":"Fraser A, Macdonald-Wallis C, Tilling K, Boyd A, Golding J, Davey Smith G, et al. Cohort profile: the avon longitudinal study of parents and children: ALSPAC mothers cohort. Int J Epidemiol. 2013;42:97\u2013110.","journal-title":"Int J Epidemiol"},{"key":"3032_CR50","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00439-003-1075-5","volume":"114","author":"A Stenzel","year":"2004","unstructured":"Stenzel A, Lu T, Koch WA, Hampe J, Guenther SM, De La Vega FM, et al. Patterns of linkage disequilibrium in the MHC region on human chromosome 6p. Hum Genet. 2004;114:377\u201385.","journal-title":"Hum Genet"},{"key":"3032_CR51","doi-asserted-by":"crossref","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13:e1007081.","journal-title":"PLoS Genet"},{"key":"3032_CR52","doi-asserted-by":"crossref","unstructured":"Robinson JW, Battram T, Baird DA, Haycock P, Zheng J, Hemani G, et al. Evaluating the potential benefits and pitfalls of combining protein and expression quantitative trait loci in evidencing drug targets. bioRxiv. https:\/\/www.biorxiv.org\/content\/10.1101\/2022.03.15.484248v1 2022.","DOI":"10.1101\/2022.03.15.484248"},{"key":"3032_CR53","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1039\/C7MD00633K","volume":"9","author":"KK Brown","year":"2018","unstructured":"Brown KK, Hann MM, Lakdawala AS, Santos R, Thomas PJ, Todd K. Approaches to target tractability assessment - a practical perspective. Medchemcomm. 2018;9:606\u201313.","journal-title":"Medchemcomm"},{"key":"3032_CR54","doi-asserted-by":"crossref","first-page":"D985","DOI":"10.1093\/nar\/gkw1055","volume":"45","author":"G Koscielny","year":"2017","unstructured":"Koscielny G, An P, Carvalho-Silva D, Cham JA, Fumis L, Gasparyan R, et al. Open Targets: a platform for therapeutic target identification and validation. Nucleic Acids Res. 2017;45:D985\u2013D994.","journal-title":"Nucleic Acids Res"},{"key":"3032_CR55","doi-asserted-by":"crossref","unstructured":"Rasooly D, Peloso GM, Pereira AC, Dashti H, Giambartolomei C, Wheeler E, et al. Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure. Nat Commun. 2023;14:3826.","DOI":"10.1038\/s41467-023-39253-3"},{"key":"3032_CR56","volume":"6","author":"TH Pers","year":"2015","unstructured":"Pers TH, Karjalainen JM, Chan Y, Westra H-J, Wood AR, Yang J, et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat Commun. 2015;6:5890.","journal-title":"Nat Commun"},{"key":"3032_CR57","volume":"22","author":"MS Lyon","year":"2021","unstructured":"Lyon MS, Andrews SJ, Elsworth B, Gaunt TR, Hemani G, Marcora E. The variant call format provides efficient and robust storage of GWAS summary statistics. Genome Biol. 2021;22:32.","journal-title":"Genome Biol"},{"key":"3032_CR58","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/bib\/bbs038","volume":"14","author":"RM Kuhn","year":"2013","unstructured":"Kuhn RM, Haussler D, Kent WJ. The UCSC genome browser and associated tools. Brief Bioinform. 2013;14:144\u201361.","journal-title":"Brief Bioinform"},{"key":"3032_CR59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.12688\/wellcomeopenres.15334.1","volume":"4","author":"VM Walker","year":"2019","unstructured":"Walker VM, Davies NM, Hemani G, Zheng J, Haycock PC, Gaunt TR, et al. Using the MR-Base platform to investigate risk factors and drug targets for thousands of phenotypes. Wellcome Open Res. 2019;4:113.","journal-title":"Wellcome Open Res"},{"key":"3032_CR60","doi-asserted-by":"crossref","first-page":"112110","DOI":"10.1016\/j.biopha.2021.112110","volume":"143","author":"F Mahmood","year":"2021","unstructured":"Mahmood F, Xu R, Awan MUN, Song Y, Han Q, Xia X, et al. PDIA3: structure, functions and its potential role in viral infections. Biomed Pharmacother. 2021;143:112110.","journal-title":"Biomed Pharmacother"},{"key":"3032_CR61","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.1038\/s41380-021-01261-4","volume":"26","author":"Y Li","year":"2021","unstructured":"Li Y, Li S, Liu J, Huo Y, Luo X-J. The schizophrenia susceptibility gene NAGA regulates dendritic spine density: further evidence for the dendritic spine pathology of schizophrenia. Mol Psychiatry. 2021;26:7102\u20134.","journal-title":"Mol Psychiatry"},{"key":"3032_CR62","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2067353","volume":"2019","author":"M Serveaux-Dancer","year":"2019","unstructured":"Serveaux-Dancer M, Jabaudon M, Creveaux I, Belville C, Blondonnet R, Gross C, et al. Pathological implications of receptor for advanced glycation end\u2010product (AGER) gene polymorphism. Dis Markers. 2019;2019:2067353.","journal-title":"Dis Markers"},{"key":"3032_CR63","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1038\/s41380-020-0753-1","volume":"25","author":"RG Mealer","year":"2020","unstructured":"Mealer RG, Williams SE, Daly MJ, Scolnick EM, Cummings RD, Smoller JW. Glycobiology and schizophrenia: a biological hypothesis emerging from genomic research. Mol Psychiatry. 2020;25:3129\u201339.","journal-title":"Mol Psychiatry"},{"key":"3032_CR64","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s12035-014-8723-8","volume":"51","author":"X-C Zhu","year":"2015","unstructured":"Zhu X-C, Yu J-T, Jiang T, Wang P, Cao L, Tan L. CR1 in Alzheimer\u2019s disease. Mol Neurobiol. 2015;51:753\u201365.","journal-title":"Mol Neurobiol"},{"key":"3032_CR65","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4103\/1673-5374.130117","volume":"9","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Peng D, Yuan X, Lv Z, Pang S, Jiang W, et al. APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer\u2019s disease. Neural Regen Res. 2014;9:653\u201360.","journal-title":"Neural Regen Res"},{"key":"3032_CR66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s40478-019-0848-6","volume":"7","author":"G Pires","year":"2019","unstructured":"Pires G, McElligott S, Drusinsky S, Halliday G, Potier M-C, Wisniewski T, et al. Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer\u2019s disease and not in other tauopathies. Acta Neuropathol Commun. 2019;7:195.","journal-title":"Acta Neuropathol Commun"},{"key":"3032_CR67","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jad.2023.12.042","volume":"348","author":"B-R Wang","year":"2024","unstructured":"Wang B-R, Wang J, Tian T, Zhang S-X, Zhao Y-Q, Meng S-Y, et al. Genetic correlation, shared loci, but no causality between bipolar disorder and inflammatory bowel disease: a genome-wide pleiotropic analysis. J Affect Disord. 2024;348:167\u201374.","journal-title":"J Affect Disord"},{"key":"3032_CR68","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/hmg\/ddab328","volume":"31","author":"A Baranova","year":"2022","unstructured":"Baranova A, Cao H, Zhang F. Shared genetic liability and causal effects between major depressive disorder and insomnia. Hum Mol Genet. 2022;31:1336\u201345.","journal-title":"Hum Mol Genet"},{"key":"3032_CR69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrm3525","volume":"14","author":"AR Kornblihtt","year":"2013","unstructured":"Kornblihtt AR, Schor IE, All\u00f3 M, Dujardin G, Petrillo E, Mu\u00f1oz MJ. Alternative splicing: a pivotal step between eukaryotic transcription and translation. Nat Rev Mol Cell Biol. 2013;14:153\u201365.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3032_CR70","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41380-021-01037-w","volume":"27","author":"C-Y Zhang","year":"2022","unstructured":"Zhang C-Y, Xiao X, Zhang Z, Hu Z, Li M. An alternative splicing hypothesis for neuropathology of schizophrenia: evidence from studies on historical candidate genes and multi-omics data. Mol Psychiatry. 2022;27:95\u2013112.","journal-title":"Mol Psychiatry"},{"key":"3032_CR71","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00213-015-3975-1","volume":"233","author":"GM Khandaker","year":"2016","unstructured":"Khandaker GM, Dantzer R. Is there a role for immune-to-brain communication in schizophrenia? Psychopharmacology. 2016;233:1559\u201373.","journal-title":"Psychopharmacology"},{"key":"3032_CR72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","volume":"181","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Ukidve A, Kim J, Mitragotri S. Targeting strategies for tissue-specific drug delivery. Cell. 2020;181:151\u201367.","journal-title":"Cell"},{"key":"3032_CR73","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.drudis.2011.09.007","volume":"16","author":"I Gashaw","year":"2011","unstructured":"Gashaw I, Ellinghaus P, Sommer A, Asadullah K. What makes a good drug target? Drug Discov Today. 2011;16:1037\u201343.","journal-title":"Drug Discov Today"},{"key":"3032_CR74","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jamapsychiatry.2021.0005","volume":"78","author":"S Chauquet","year":"2021","unstructured":"Chauquet S, Zhu Z, O\u2019Donovan MC, Walters JTR, Wray NR, Shah S. Association of antihypertensive drug target genes with psychiatric disorders: A Mendelian randomization study. JAMA Psychiatry. 2021;78:623\u201331.","journal-title":"JAMA Psychiatry"},{"key":"3032_CR75","volume":"8","author":"DK Ryan","year":"2022","unstructured":"Ryan DK, Karhunen V, Su B, Traylor M, Richardson TG, Burgess S, et al. Genetic evidence for protective effects of angiotensin-converting enzyme against Alzheimer disease but not other neurodegenerative diseases in european populations. Neurol Genet. 2022;8:e200014.","journal-title":"Neurol Genet"},{"key":"3032_CR76","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/aje\/kwv451","volume":"184","author":"ER Mayeda","year":"2016","unstructured":"Mayeda ER, Tchetgen Tchetgen EJ, Power MC, Weuve J, Jacqmin-Gadda H, Marden JR, et al. A simulation platform for quantifying survival bias: an application to research on determinants of cognitive decline. Am J Epidemiol. 2016;184:378\u201387.","journal-title":"Am J Epidemiol"},{"key":"3032_CR77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002314","volume":"14","author":"AJ Noyce","year":"2017","unstructured":"Noyce AJ, Kia DA, Hemani G, Nicolas A, Price TR, De Pablo-Fernandez E, et al. Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study. PLoS Med. 2017;14:e1002314.","journal-title":"PLoS Med"},{"key":"3032_CR78","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1081\/CEH-120024988","volume":"25","author":"J Michael Wyss","year":"2003","unstructured":"Michael Wyss J, Kadish I, van Groen T. Age\u2010related decline in spatial learning and memory: attenuation by captopril. Clin Exp Hypertens. 2003;25:455\u201374.","journal-title":"Clin Exp Hypertens"},{"key":"3032_CR79","volume":"19","author":"RE Mitchell","year":"2023","unstructured":"Mitchell RE, Hartley AE, Walker VM, Gkatzionis A, Yarmolinsky J, Bell JA, et al. Strategies to investigate and mitigate collider bias in genetic and Mendelian randomisation studies of disease progression. PLoS Genet. 2023;19:e1010596.","journal-title":"PLoS Genet"},{"key":"3032_CR80","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1192\/bjp.bp.110.084384","volume":"198","author":"MJ Owen","year":"2011","unstructured":"Owen MJ, O\u2019Donovan MC, Thapar A, Craddock N. Neurodevelopmental hypothesis of schizophrenia. Br J Psychiatry. 2011;198:173\u20135.","journal-title":"Br J Psychiatry"},{"key":"3032_CR81","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/gepi.21998","volume":"40","author":"S Burgess","year":"2016","unstructured":"Burgess S, Davies NM, Thompson SG. Bias due to participant overlap in two\u2010sample Mendelian randomization. Genet Epidemiol. 2016;40:597\u2013608.","journal-title":"Genet Epidemiol"},{"key":"3032_CR82","doi-asserted-by":"publisher","unstructured":"Sadreev II, Elsworth BL, Mitchell RE, Paternoster L, Sanderson E, Davies NM, et al. Navigating sample overlap, winner\u2019s curse and weak instrument bias in Mendelian randomization studies using the UK biobank. medRxiv: 2021.06.28.21259622 [Preprint]. 2021. https:\/\/doi.org\/10.1101\/2021.06.28.21259622.","DOI":"10.1101\/2021.06.28.21259622"},{"key":"3032_CR83","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/ije\/dyw127","volume":"45","author":"DA Lawlor","year":"2016","unstructured":"Lawlor DA, Tilling K, Davey Smith G. Triangulation in aetiological epidemiology. Int J Epidemiol. 2016;45:1866\u201386.","journal-title":"Int J Epidemiol"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03032-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03032-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03032-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T15:43:13Z","timestamp":1757950993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03032-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":83,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["3032"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-03032-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.02.16.24302885","asserted-by":"object"}]},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JWR is a full-time employee of Boehringer Ingelheim but undertook all relevant work when at the University of Bristol. TGR is a full-time employee of GlaxoSmithKline outside of this work. No funding body has influenced data collection, analyses, or their interpretation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"ALSPAC data used as reference panel: ethical approval was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Consent for biological samples has been collected in accordance with the Human Tissue Act (2004).We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, and nurses. GWAS data: across all analyses summary data were used. These data are publicly available for research purposes. Details on the ethics declarations for each GWAS study can be found in the original publications. All analyses were conducted in accordance with the protocols and guidelines provided by the authors of the original methods.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}